Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-2259
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-10-26T06:45:23.645713Z
status: published
lens: g_space
sector: health
headline: Prognostic risk stratification in glioma based on the foundation pathology model with identification of key genes and biological pathways associated with prognosis: a multicenter study
dek: Abstract Purpose: Artificial intelligence(AI)-based feature extraction from whole slide images (WSIs) shows significant promise for glioma prognosis. However, while foundation pathology models have potential, their features typically lack biological interpretability and clear links to disease mechanisms, limiting their clinical translational value. Methods: We propose a clustering Vision Transformer (ViT)–based framework for pathological image analysis. Tens of thousands of image patches extracted from each WSI…
gain_title: An AI model using clustered pathology slide features produced risk scores tied to glioma survival and improved a clinical-molecular nomogram, while also pointing to risk-associated genes and pathways.
problem_title: (none)
trace_subject: (none)
gain_reading: An AI model using clustered pathology slide features produced risk scores tied to glioma survival and improved a clinical-molecular nomogram, while also pointing to risk-associated genes and pathways.
gain_evidence: Risk scores produced by the prognostic model showed a significant correlation with patient survival (log-rank P < 0.001)
problem_reading: (none)
problem_evidence: (none)
quick_read: Researchers built a framework that splits tens of thousands of image patches from each glioma whole slide image into 100 clusters. It feeds the foundation-model features of the cluster centroids, plus each cluster's share of the slide, into a Vision Transformer that predicts prognosis.

The approach tackles the weak biological interpretability of foundation pathology models by pairing image-derived risk scores with matched RNA-seq data. That pairing surfaces genes and pathways tied to risk and suggests immune microenvironment therapies might help high-risk patients, though this is a suggestion rather than a tested treatment result.
limitation: 
tag: Evidence-backed gain
key_points: Prognostic prediction was developed and evaluated in 2552 cases across Huashan Hospital, Shanghai International Hospital and TCGA. | Adding the risk score to a clinical nomogram gave a C-index of 0.90 and a net reclassification improvement of 0.99. | Pathogenomic analyses used 567 TCGA cases with matched slides and RNA-seq data, then were validated in 657 CGGA cases. | Mean expression of the identified key genes showed strong prognostic value in both the TCGA pathogenomics cohort and the CGGA dataset.
rundown: The study design used 559 Huashan Hospital cases for training and internal testing, 309 Shanghai International Hospital cases as external validation cohort 1, and 1684 TCGA cases as external validation cohort 2.

Image-derived risk scores were combined with RNA-seq data through differential expression and pathway enrichment analyses to identify genes and pathways associated with risk.

The authors conclude that therapies modulating the tumor immune microenvironment may be particularly beneficial for patients the approach identifies as high risk.
sources:
- peer_reviewed | Acta Neuropathologica Communications | https://doi.org/10.1186/s40478-026-02456-y | 2026-10-24
prev: 0000000000000000000000000000000000000000000000000000000000000000

sha256

fe159fd7e6e6ef9d0222b57a3db57ac8b78d1b0f40ba1de46c5e9eff29b32573

previous

0000000000000000000000000000000000000000000000000000000000000000